Covid-19 vaccine hopes and the bitter reality

Loading player...
There have been some promising early trials of various nascent Covid-19 vaccines, and many are hoping for a usable shot by year-end. In reality, however, we are in the very early days yet and promising early-stage trials are no guarantee of success. What’s more, the rollout of any Covid-19 vaccine promises to be a contentious political process, with the US and China staking out aggressive positions on who will have early access. In this episode, featuring content from the Bloomberg P&L podcast, we explore these issues and why we should be moderating our vaccine hopes. Bottom line: It looks like we need to learn to live with Covid-19, rather than pinning our hopes on a quick-fix vaccine solution. Learn more about your ad choices. Visit megaphone.fm/adchoices
24 May 2020 7AM English South Africa Investing · Business News

Other recent episodes

BN Edge | Piet le Roux: ICASA, Starlink and the true cost of BEE

To sell internet access in South Africa, you first have to show ICASA the race of your shareholders. Sakeliga has now taken the regulator to the Pretoria High Court, but, oddly, not to scrap the 30% black-ownership rule. Chief executive Piet le Roux told Alec Hogg why he chose the…
13 Nov 6AM 28 min